RESUMO
BACKGROUND: The exposure patterns across ethnic groups are unclear for stomach bugs that cause self-limiting symptoms, significantly burdening UK health-care services and the economy. This study seeks to fill this gap by exploring how inequalities arise in managing stomach bugs in UK ethnic groups. METHODS: A qualitative study using semi-structured interviews was undertaken. Ethics approval was given by the University of Liverpool, and data were collected by IZ over 11 months from July 26, 2022, and May 26, 2023. Purposive sampling was used to recruit a general UK population sample (excluding health-care professionals) who were adults, partners, and parents, from an ethnic minority group, with recent diarrhoea, vomiting, or a stomach bug over the past 6 months. Recruitment was conducted through community gatekeepers using flyers. Participants were interviewed in person or virtually and gave written informed consent. An incentive of an Amazon voucher of £10 was imbursed to participants for their time. Interviews were audio-recorded using a password-protected digital recorder, transcribed verbatim, and analysed using reflexive thematic analysis. FINDINGS: 36 interviews (median age 31·5 years) were conducted with 11 women of Pakistani (n=6), Bangladeshi (n=2), Indian (n=2) and Arab ethnicity (n=1), and 25 men of Black (n=22), Pakistani (n=2), and Indian (n=1) ethnicity. This sample enabled an exploration of within-ethnic group experiences of stomach bugs in participants who self-defined their age, sex, and ethnicity. Themes such as managing food preparation (n=16), travel abroad (n=17), and personal cleanliness (n=3) were consistently reported across transcripts. The findings corroborate existing literature that there are more similarities than divergences in the management of stomach bugs across ethnic groups, such as the burden of care disproportionately affecting women and using over-the-counter medication to manage symptoms. INTERPRETATION: We do not know if the impact of these experiences across ethnic groups is entirely representative of the broader ethnic categories (ie, Asian vs Indian, Pakistani, and Bangladeshi) they belong to or if there are inequalities in their impact on ethnic groups living in different circumstances (ie, UK born vs migrant). FUNDING: National Institute for Health and Care Research (NIHR).
Assuntos
Diarreia , Grupos Minoritários , Gastropatias , Estômago , Vômito , Adulto , Feminino , Humanos , Masculino , Povo Asiático , Etnicidade , Estômago/microbiologia , Reino Unido/epidemiologia , Pesquisa Qualitativa , População Negra , Diarreia/etnologia , Diarreia/microbiologia , Vômito/etnologia , Vômito/microbiologia , Gastropatias/etnologia , Gastropatias/microbiologiaAssuntos
Dor Abdominal/fisiopatologia , COVID-19/fisiopatologia , Diarreia/fisiopatologia , Etnicidade , Náusea/fisiopatologia , Vômito/fisiopatologia , Dor Abdominal/etnologia , Adolescente , Negro ou Afro-Americano , COVID-19/etnologia , Criança , Pré-Escolar , Tosse/fisiopatologia , Diarreia/etnologia , Feminino , Febre/fisiopatologia , Disparidades nos Níveis de Saúde , Hispânico ou Latino , Humanos , Lactente , Recém-Nascido , Masculino , Náusea/etnologia , SARS-CoV-2 , Estados Unidos , Vômito/etnologia , População Branca , Adulto JovemRESUMO
BACKGROUND: The increase in adiposity problems among United States adolescents has been accompanied by persistently high prevalence of unhealthy dieting behaviours (UDBs) such as fasting, taking diet pills/powders/liquids, and vomiting/taking laxatives. This study aimed to examine the associations of self-perceptions of weight status, weight change intentions (WCIs) and UDBs with sex, age and race, as well as trends of UDBs in American adolescents across the weight spectrum. METHODS: Data come from the biennial cross-sectional, school-based surveys, the Youth Risk Behaviour Surveillance System (1999-2013, n = 113,542). The outcome measures were the self-reported UDBs: fasting for 24 h or more; taking diet pills/powders/liquids; and vomiting/taking laxatives. Sex-stratified logistic regressions assessed relationships between weight status misperceptions across all weight statuses, race and WCIs with UDBs. Differential trends between races were assessed using race*year interaction terms. RESULTS: In males, all non-White races had higher odds of fasting and vomiting/taking laxatives than Whites (except fasting in Hispanic/Latinos), with Adjusted Odds Ratios (AORs) between 1.44 and 2.07. In females, Black/African Americans and Hispanic/Latinos had lower odds of taking diet pills/powders/liquids compared to Whites (AORs 0.50 and 0.78 respectively). Racial disparities persisted throughout the study period. Prevalence of fasting and vomiting/taking laxatives did not change between 1999 and 2013 for all races, while taking diet pills/powders/liquids decreased. Compared to individuals of normal weight who were accurate weight status perceivers, individuals of almost all other combinations of weight status and weight status perception had significantly higher odds of displaying any UDB outcome. Overestimation of weight status was found to be the strongest determinant of UDBs. Compared to individuals endorsing "not wanting to do anything" about their weight, individuals endorsing all other WCIs (including wanting to gain weight) also showed significantly higher odds for every UDB outcome, with wanting to lose weight having AORs of the greatest magnitudes. CONCLUSIONS: Prevalence of UDBs is persistently high, and highest among females across all racial groups. UDBs may elevate undesired weight gain and weight loss in individuals who are obese/overweight and underweight respectively. Further research into weight status perceptions among adolescents may inform efforts to reduce UDBs.
Assuntos
Comportamento do Adolescente/psicologia , Dieta Redutora/psicologia , Comportamentos de Risco à Saúde , Adolescente , Comportamento do Adolescente/etnologia , Fármacos Antiobesidade/administração & dosagem , Peso Corporal , Estudos Transversais , Dieta Redutora/etnologia , Jejum/psicologia , Feminino , Humanos , Laxantes/administração & dosagem , Masculino , Grupos Raciais/psicologia , Grupos Raciais/estatística & dados numéricos , Fatores de Risco , Autoimagem , Fatores Sexuais , Estados Unidos , Vômito/etnologia , Vômito/psicologiaRESUMO
OBJECTIVE: This study examined the mediating role of body dissatisfaction between Body Mass Index (BMI) and subsequent disordered eating (e.g. dieting and restricting/purging) among early adolescent African American girls. STUDY DESIGN: Participants included 701 African American girls in 6th and 7th grades in urban schools serving low-income communities, mean age 12.15 (SDâ¯=â¯0.72) years. Participants were assessed at baseline and approximately 6â¯months later. Objectively measured height and weight were used to calculate BMI z-score. Participants completed questionnaires on body size dissatisfaction and recent dieting and restricting/purging behaviors. RESULTS: At baseline, 51.5% of participants were overweight/obese, and 60.4% expressed body dissatisfaction and a desire to be smaller. Path analytic analyses revealed change in body dissatisfaction significantly mediates the relation between initial BMI z-score and increases in dieting behaviors (Bâ¯=â¯0.924, SEâ¯=â¯0.280, pâ¯=â¯0.001) but not restricting/purging behaviors (pâ¯=â¯0.05). CONCLUSIONS: Body dissatisfaction explains some associations between excess body weight and subsequent disordered eating symptoms among early adolescent, African American girls. Body dissatisfaction, identified by screening, may be an indicator of further negative consequences, including disordered eating behaviors.
Assuntos
Negro ou Afro-Americano/psicologia , Imagem Corporal/psicologia , Índice de Massa Corporal , Transtornos da Alimentação e da Ingestão de Alimentos/etnologia , Sobrepeso/etnologia , População Urbana , Adolescente , Negro ou Afro-Americano/estatística & dados numéricos , Criança , Dieta Redutora/etnologia , Feminino , Humanos , Obesidade/etnologia , Satisfação Pessoal , Fatores de Risco , População Urbana/estatística & dados numéricos , Vômito/etnologiaRESUMO
PURPOSE: Racial minority cancer patients may experience underuse of antiemetic medications to prevent chemotherapy-induced nausea and vomiting (CINV). In addition to its adverse implications for quality of life, antiemetic underuse may contribute to observed disparities in acute illness during chemotherapy. To understand the potential contribution of CINV prophylaxis to breast cancer disparities, we assessed racial variation in potent antiemetic use and post-chemotherapy utilization related to CINV and the relationship between the two. METHODS: We used SEER-Medicare data to evaluate the health care utilization in the 14 days following chemotherapy initiation among black and white women receiving highly emetogenic chemotherapy for breast cancer. We used modified Poisson regression to assess the relationship between (1) race and CINV-related utilization and (2) NK1 use and CINV-related utilization, overall and stratified by race. We report adjusted risk ratios (aRR) and 95 % confidence intervals (CI). RESULTS: The study included 1130 women. Black women were 11 % less likely than white women to use neurokinin-1 receptor antagonists (NK1s) for CINV prophylaxis (p = 0.02); however, they experienced fewer CINV-related encounters following chemotherapy (unadjusted RR = 0.63, 95 %CI = 0.40-0.99; p = 0.05). After adjustment for clinical covariates, estimates were similar but no longer statistically significant (p = 0.07). Among white women, NK1 use was associated with increased CINV-related utilization (aRR NK1 users vs. non-users: 1.35, 95 % CI = 1.07-1.69, p = 0.01), likely resulting from unmeasured confounders. CONCLUSION: Black women were less likely to use NK1s- and CINV-related services. Racial variation in CINV-related services use may be partly explained by differential symptom reporting or access to care.
Assuntos
Antieméticos/uso terapêutico , Antineoplásicos/efeitos adversos , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/etnologia , Náusea/etnologia , Antagonistas dos Receptores de Neurocinina-1/uso terapêutico , Aceitação pelo Paciente de Cuidados de Saúde/etnologia , Grupos Raciais , Vômito/etnologia , Idoso , Idoso de 80 Anos ou mais , População Negra , Feminino , Humanos , Náusea/induzido quimicamente , Qualidade de Vida , Vômito/induzido quimicamenteRESUMO
Chemotherapy-induced nausea and vomiting (CINV) is a major concern for cancer patients and, if uncontrolled, can seriously compromise quality of life (QOL) and other treatment outcomes. Because of the expense of antiemetic medications used to prevent CINV (particularly oral medications filled through Medicare Part D), disparities in their use may exist. We used 2006-2012 SEER-Medicare data to evaluate the use of neurokinin-1 receptor antagonists (NK1s), a potent class of antiemetics, among black and white women initiating highly emetogenic chemotherapy for the treatment of early-stage breast cancer. We used modified Poisson regression to assess the relationship between race and (1) any NK1 use, (2) oral NK1 (aprepitant) use, and (3) intravenous NK1 (fosaprepitant) use. We report adjusted risk ratios (aRR) and 95 % confidence intervals (CI). The study included 1130 women. We observed racial disparities in use of any NK1 (aRR: 0.68, 95 % CI 0.51-0.91) and in use of oral aprepitant specifically (aRR: 0.54, 95 % CI 0.35-0.83). We did not observe disparities in intravenous fosaprepitant use. After controlling for variables related to socioeconomic status, disparities in NK1 and aprepitant use were reduced but not eliminated. We found racial disparities in women's use of oral NK1s for the prevention of CINV. These disparities may be partly explained by racial differences in socioeconomic status, which may translate into differential ability to afford the medication.
Assuntos
Antineoplásicos/efeitos adversos , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/etnologia , Náusea/prevenção & controle , Antagonistas dos Receptores de Neurocinina-1/administração & dosagem , Vômito/prevenção & controle , Administração Intravenosa , Administração Oral , Antineoplásicos/uso terapêutico , População Negra/estatística & dados numéricos , Feminino , Humanos , Morfolinas/administração & dosagem , Morfolinas/uso terapêutico , Náusea/induzido quimicamente , Náusea/etnologia , Antagonistas dos Receptores de Neurocinina-1/uso terapêutico , Qualidade de Vida , Análise de Regressão , Programa de SEER , Fatores Socioeconômicos , Resultado do Tratamento , Vômito/induzido quimicamente , Vômito/etnologia , População Branca/estatística & dados numéricosRESUMO
This randomised, double-blind, multicentre study with children nine-23 months old evaluated the immunogenicity of yellow fever (YF) vaccines prepared with substrains 17DD and 17D-213/77. YF antibodies were tittered before and 30 or more days after vaccination. Seropositivity and seroconversion were analysed according to the maternal serological status and the collaborating centre. A total of 1,966 children were randomised in the municipalities of the states of Mato Grosso do Sul, Minas Gerais and São Paulo and blood samples were collected from 1,714 mothers. Seropositivity was observed in 78.6% of mothers and 8.9% of children before vaccination. After vaccination, seropositivity rates of 81.9% and 83.2%, seroconversion rates of 84.8% and 85.8% and rates of a four-fold increase over the pre-vaccination titre of 77.6% and 81.8% were observed in the 17D-213/77 and 17DD subgroups, respectively. There was no association with maternal immunity. Among children aged 12 months or older, the seroconversion rates of 69% were associated with concomitant vaccination against measles, mumps and rubella. The data were not conclusive regarding the interference of maternal immunity in the immune response to the YF vaccine, but they suggest interference from other vaccines. The failures in seroconversion after vaccination support the recommendation of a booster dose in children within 10 years of the first dose.
Assuntos
Humanos , Masculino , Feminino , Lactente , Anticorpos Antivirais/isolamento & purificação , Antivirais/uso terapêutico , Soroconversão , Vacina contra Febre Amarela/imunologia , Vírus da Febre Amarela/imunologia , Febre Amarela/prevenção & controle , Anticorpos Neutralizantes , Causalidade , Diarreia/etnologia , Método Duplo-Cego , Febre/etnologia , Técnica de Placa Hemolítica , Rouquidão/etnologia , Convulsões/etnologia , Resultado do Tratamento , Vômito/etnologia , Vacina contra Febre Amarela/efeitos adversos , Vírus da Febre Amarela/classificaçãoRESUMO
INTRODUCTION: Domperidone is a dopamine receptor antagonist with peripheral prokinetic and central antiemetic properties. Prolongation of the QTc interval with chronic use of oral domperidone in standard doses has been reported in the literature. Our goal was to investigate cardiac toxicity in patients receiving 2-fold greater doses than in previous reports. METHODS: A retrospective chart review was conducted of patients with nausea (N) and vomiting (V) receiving domperidone from 2009 to 2013 under an Investigational New Drug (IND) protocol. Patient demographics, indications for therapy, clinical outcomes, cardiac symptoms and electrocardiogram tracings were reviewed. Prolonged QTc was verified if >470 milliseconds in females (F) and >450 milliseconds in males (M). RESULTS: A total of 64 patients, 44 female (37% Hispanic, 60% white, 3% African American), were taking domperidone for diabetic gastroparesis 45%; idiopathic gastroparesis 36%; chronic N&V 8%; dumping syndrome 5%; cyclic vomiting 5% and conditioned vomiting 1%. Mean duration of therapy was 8 months (range, 3 months to 4 years). Doses ranged from 40 to 120 mg/d with 90% receiving 80 to 120 mg compared with the standard dose of 40 mg. Of note, 73% of subjects benefited from treatment with reduced nausea and vomiting. Thirty-seven patients had follow-up electrocardiograms available, and they showed that the mean QTc at baseline was 424 milliseconds ± 28.4 (SD) compared with 435 milliseconds ± 27.2 (SD) at follow-up (not significant). Ten of these patients had prolonged QTc at F/U ranging from 453 to 509 milliseconds, without any cardiovascular complaints. There was no relationship between prolonged QTc and daily dose of domperidone, body mass index or age. CONCLUSIONS: Our data indicate that at very high dosing, the prokinetic/antiemetic agent domperidone has a low risk of adverse cardiovascular events while exhibiting good clinical efficacy.
Assuntos
Cardiotoxicidade , Domperidona , Náusea/tratamento farmacológico , Vômito/tratamento farmacológico , Adulto , Cardiotoxicidade/diagnóstico , Cardiotoxicidade/etnologia , Cardiotoxicidade/etiologia , Domperidona/administração & dosagem , Domperidona/efeitos adversos , Antagonistas de Dopamina/administração & dosagem , Antagonistas de Dopamina/efeitos adversos , Relação Dose-Resposta a Droga , Monitoramento de Medicamentos , Eletrocardiografia/métodos , Feminino , Humanos , Masculino , Náusea/etnologia , Náusea/etiologia , Estudos Retrospectivos , Tempo , Resultado do Tratamento , Estados Unidos/epidemiologia , Vômito/etnologia , Vômito/etiologiaRESUMO
BACKGROUND: Neuromyelitis optica (NMO) is a severe autoimmune disease of the central nervous system characterized by spinal cord and optic nerve involvement. Brainstem manifestations have recently been described. OBJECTIVE: To evaluate the time of occurrence, the frequency and the characteristics of brainstem symptoms in a cohort of patients with NMO according to the ethnic background and the serologic status for anti-aquaporin-4 antibodies (AQP4-abs). METHODS: We performed a multicenter study of 258 patients with NMO according to the 2006 Wingerchuk criteria and we evaluated prospectively the frequency, the date of onset and the duration of various brainstem signs in this population. RESULTS: Brainstem signs were observed in 81 patients (31.4%). The most frequently observed signs were vomiting (33.1%), hiccups (22.3%), oculomotor dysfunction (19.8%), pruritus (12.4%), followed by hearing loss (2.5%), facial palsy (2.5%), vertigo or vestibular ataxia (1.7%), trigeminal neuralgia (2.5%) and other cranial nerve signs (3.3%). They were inaugural in 44 patients (54.3%). The prevalence was higher in the non-Caucasian population (36.6%) than in the Caucasian population (26%) (p<0.05) and was higher in AQP4-ab-seropositive patients (32.7%) than in seronegative patients (26%) (not significant). CONCLUSIONS: This study confirms the high frequency of brainstem symptoms in NMO with a majority of vomiting and hiccups. The prevalence of these manifestations was higher in the non Caucasian population.
Assuntos
Tronco Encefálico/fisiopatologia , Soluço/fisiopatologia , Neuromielite Óptica/fisiopatologia , Vômito/fisiopatologia , Adulto , Aquaporina 4/imunologia , Autoanticorpos/sangue , Biomarcadores/sangue , Tronco Encefálico/diagnóstico por imagem , Tronco Encefálico/imunologia , Europa (Continente) , Feminino , Soluço/diagnóstico , Soluço/etnologia , Soluço/imunologia , Humanos , Japão , Imageamento por Ressonância Magnética , Masculino , Neuromielite Óptica/diagnóstico , Neuromielite Óptica/etnologia , Neuromielite Óptica/imunologia , América do Norte , Prevalência , Fatores de Risco , Testes Sorológicos , Vômito/diagnóstico , Vômito/etnologia , Vômito/imunologiaRESUMO
BACKGROUND: Chemotherapy-induced nausea and vomiting (CINV) remain prevalent among cancer patients despite pharmacological advances in CINV therapy. Patients can initiate nonpharmacologic strategies, which potentially play an important role as adjuncts to pharmacological agents in alleviating CINV. Some studies have explored nausea and vomiting self-management (NVSM) behaviors among patients in Western settings; however, little is known about the NVSM behaviors of patients in China. OBJECTIVES: This study examines NVSM behaviors of Chinese cancer patients. METHODS: A cross-sectional survey was conducted in a specialist cancer hospital in southeast China. RESULTS: A sample of 255 cancer patients was recruited. A mean of 8.56 (±3.15) NVSM behaviors was reported. Most NVSM behaviors were rated as moderately effective and were implemented with moderate self-efficacy. Higher distress levels, better functional status, previous similar symptom experiences, receiving chemotherapy as an inpatient, and greater support from multiple levels were related to greater engagement in NVSM; higher self-efficacy levels pertaining to NVSM behaviors were associated with reports of more relief from specific NVSM behaviors. CONCLUSIONS: A range of NVSM strategies was initiated by Chinese cancer patients and provided some relief. A range of individual, health status, and environmental factors influenced engagement with and relief from NVSM behaviors. IMPLICATIONS FOR PRACTICE: To enhance Chinese patients' NVSM, patients should be supported to engage in behaviors including taking antiemetics, modifying their diet, using psychological strategies, and creating a pleasant environment. The findings highlight the importance of enhancing patients' self-efficacy in NVSM, alleviating symptom distress, and improving social support to achieve better outcomes.
Assuntos
Povo Asiático , Náusea/enfermagem , Neoplasias/enfermagem , Autocuidado , Vômito/enfermagem , Adulto , Antineoplásicos/efeitos adversos , Povo Asiático/estatística & dados numéricos , China/epidemiologia , Estudos Transversais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Náusea/induzido quimicamente , Náusea/etnologia , Neoplasias/tratamento farmacológico , Neoplasias/etnologia , Inquéritos e Questionários , Vômito/induzido quimicamente , Vômito/etnologiaRESUMO
INTRODUCTION: Nausea and vomiting are recognized as two separate and distinct conditions with a wide spectrum of etiologies either directly associated with cancer itself or its treatment. According to the new ranking of chemotherapy side effects, nausea is the number one or the most disturbing side effects while vomiting is the third and sometimes the fifth. The introduction of 5-HT3-recptor antagonists in the early of 1990s has revolutionized the treatment of nausea and vomiting, these agents remaining the mainstay of antiemetic therapy today. Ethnic variation (due to genetic polymorphisms) may lead to diversity in antiemetic treatment pharmacokinetic and pharmacodynamic properties, in terms of distribution, elimination, disposition and clinical effects. The aim of the present study was to clarify genetic polymorphism effects in the three main races in Malaysia i.e., Malay, Chinese and Indian, on the clinical antiemetic effects of granisetron. METHODS: In this longitudinal prospective observational study, 158 breast cancer patients treated with chemotherapy were monitored for nausea and vomiting in the first 24 hours after chemotherapy administration. The patients were then followed up again after 3 to 5 days of chemotherapy. RESULTS: Genetic polymorphisms in the three races in Malaysia have significant effect on granisetron clinical antiemetic action because each is characterized by variant CYP3A4 enzymatic action. CONCLUSION: According to the result, different type of 5-HT3 receptor antagonists, such as tropisetron and dolasetron which are predominantly metabolized by CYP2D6, should be used especially for Chinese breast cancer patients.
Assuntos
Antieméticos/uso terapêutico , Antineoplásicos/efeitos adversos , Granisetron/uso terapêutico , Náusea/tratamento farmacológico , Náusea/genética , Vômito/tratamento farmacológico , Vômito/genética , Adulto , Idoso , Antineoplásicos/uso terapêutico , Neoplasias da Mama/tratamento farmacológico , Citocromo P-450 CYP3A/genética , Feminino , Seguimentos , Humanos , Estudos Longitudinais , Malásia , Pessoa de Meia-Idade , Náusea/induzido quimicamente , Náusea/etnologia , Estadiamento de Neoplasias/métodos , Polimorfismo Genético , Estudos Prospectivos , Antagonistas do Receptor 5-HT3 de Serotonina/uso terapêutico , Vômito/induzido quimicamente , Vômito/etnologiaRESUMO
OBJECTIVES: Ethnic disparities in childhood overweight are well-documented. In addition, disordered weight control behaviors (DWCB) have been linked to overweight and weight gain in multiple ways, but little is known about DWCB in youth of color, especially boys. We examined the distribution and determinants of ethnic and gender disparities in DWCB in early adolescents. METHODS: In fall 2005, 47 Massachusetts middle schools participating in the Healthy Choices overweight prevention study administered a self-report baseline survey assessing student sociodemographics, height, weight, and DWCB (vomiting or use of laxatives or diet pills in the past month to control weight). Data from 16,978 girls and boys were used in multivariate logistic regression models to estimate the odds of DWCB in youth of color compared with their white peers, controlling for individual- and school-level factors. RESULTS: Among white youth, 2.7% of girls and 2.3% of boys reported DWCB. The odds of DWCB were elevated 2-10 times in most ethnic groups relative to whites. Disparities were attenuated but persisted after controlling for multiple individual- and school-level factors. CONCLUSIONS: Ethnic disparities in DWCB must be considered in efforts to address the epidemic of childhood overweight.
Assuntos
Comportamento do Adolescente/etnologia , Atitude Frente a Saúde/etnologia , Negro ou Afro-Americano/estatística & dados numéricos , Transtornos da Alimentação e da Ingestão de Alimentos/etnologia , População Branca/estatística & dados numéricos , Adolescente , Anorexia Nervosa/etnologia , Depressores do Apetite/administração & dosagem , Transtorno da Compulsão Alimentar/etnologia , Bulimia Nervosa/etnologia , Diuréticos/administração & dosagem , Transtornos da Alimentação e da Ingestão de Alimentos/prevenção & controle , Feminino , Humanos , Laxantes/administração & dosagem , Masculino , Massachusetts/epidemiologia , Obesidade/etnologia , Análise de Regressão , Fatores de Risco , Vômito/etnologiaRESUMO
PURPOSE: A prospective survey was undertaken to investigate ethnic variations in the frequency of nausea and vomiting after fundus fluorescein angiography (FFA). METHOD: Between May and September 1998, 197 adult patients were recruited to the study. A questionnaire containing closed-ended questions was completed by nurses after each FFA and a questionnaire was given to patients to complete 5 hours after the procedure at home. Patients' anxiety level was measured before FFA using a 5-item ordinal response scale. RESULTS: Results indicate that patients from black, Asian, Chino-Asian and mixed ethnic origins are significantly more likely to vomit and feel nauseous immediately after the administration of fluorescein dye. Patients with a history of nausea after FFA are significantly more likely to feel nauseous again after repeat FFA. CONCLUSION: Ethnic origin and a previous history of nausea and vomiting appear to be important factors in FFA-induced nausea and vomiting. The results of this study have led the investigators to develop a protocol for the prophylactic treatment of nausea and vomiting following FFA.
Assuntos
Angiofluoresceinografia/efeitos adversos , Fluoresceínas/efeitos adversos , Corantes Fluorescentes/efeitos adversos , Náusea/etnologia , Vômito/etnologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Ansiedade/etnologia , Inglaterra/epidemiologia , Oftalmopatias/diagnóstico , Feminino , Humanos , Iluminação/efeitos adversos , Masculino , Pessoa de Meia-Idade , Náusea/induzido quimicamente , Estudos Prospectivos , Recidiva , Vômito/induzido quimicamenteRESUMO
Professional and indigenous midwives are rich and appropriate sources of information about antenatal comfort measures. Midwives from a variety of geographic and cultural areas were interviewed to further our understanding of the phenomenon of nausea and vomiting during pregnancy (NVP). The midwives offered general physiological, psychological, and socioeconomic etiological theories that were, at times, inconsistent with their recommended remedies. The remedies generally included alterations in maternal nutrition, activity, and environment. Commonalities in the midwives theories of etiology and treatment were found across culturally and geographically diverse groups. Much of the variation that was noted in the midwives recommendations for treatment was related to (a) availability of a specific remedy and (b) the midwife's willingness to either support or discourage intuitive responses that women have to their pregnancies (e.g., encourage either additional rest or exercise and productive activity; social withdrawal or usual social interaction; and pica and food cravings or a balanced diet with high nutritive value).
Assuntos
Atitude do Pessoal de Saúde , Atitude Frente a Saúde/etnologia , Medicina Tradicional , Tocologia/métodos , Náusea/etnologia , Náusea/prevenção & controle , Complicações na Gravidez/etnologia , Vômito/etnologia , Vômito/prevenção & controle , Adulto , Feminino , Humanos , Náusea/etiologia , Pesquisa em Avaliação de Enfermagem , Teoria de Enfermagem , Gravidez , Inquéritos e Questionários , Vômito/etiologiaRESUMO
This paper discusses research designed to investigate community, clinic, and longitudinal patterns in use of lead as a treatment for empacho, a folk illness manifest by gastrointestinal symptoms. The same questionnaire used in a clinic-based study seven years previously in Guadalajara, Mexico, was used to interview a randomly selected community sample: in addition, the study was repeated at the same clinic sites that had been studied previously. The goals were to investigate: (1) What are community wide prevalences of empacho and use of lead based remedies? (2) To what extent are current patterns of use of lead for treatment of empacho in clinic-based samples similar to those seven years ago. The attributable risk to the population as a whole from use of lead based remedies was found to be 11% of the households of Guadalajara. Essentially this same estimate was seen for the 1987 and 1994 clinic populations. Interestingly, while percentages of lead users have declined since 1987, twice as great a percentage of informants reported treating empacho. Other patterns originally identified in 1987 persisted in 1994; lead use continues to be associated with lower levels of parental education and income.
Assuntos
Diarreia/tratamento farmacológico , Conhecimentos, Atitudes e Prática em Saúde , Chumbo/uso terapêutico , Medicina Tradicional , Vômito/tratamento farmacológico , Adulto , Instituições de Assistência Ambulatorial , Criança , Diarreia/etnologia , Feminino , Seguimentos , Humanos , Masculino , México , Mães/educação , Mães/psicologia , Fatores Socioeconômicos , Inquéritos e Questionários , Vômito/etnologiaRESUMO
Nausea and vomiting have been recognized as the most distressing side effects of chemotherapy, and are experienced by 66-91% of chemotherapy patients in Japan. Relaxation measures have been used for patients with various other diagnoses, but this technique has never been applied to patients receiving cancer chemotherapy. This pilot study examined the effects of progressive muscle relaxation (PMR) to reduce nausea, vomiting, and anxiety associated with chemotherapy in Japanese patients. Data for eight subjects who were randomly assigned to a treatment group or a control group were analyzed. Both treatment and control groups showed decrease in nausea and vomiting; therefore, the effect of PMR was not verified. However, there was an average decrease of 2.5 points in state-anxiety scores in the treatment group. In addition, some positive effects of PMR were shown by the subjects in the treatment group.
Assuntos
Antineoplásicos/efeitos adversos , Relaxamento Muscular , Náusea/prevenção & controle , Vômito/prevenção & controle , Adulto , Idoso , Ansiedade/prevenção & controle , Demografia , Feminino , Humanos , Japão , Masculino , Pessoa de Meia-Idade , Náusea/etnologia , Projetos Piloto , Testes Psicológicos , Vômito/etnologiaRESUMO
The role of maternal risk factors in the development of nausea and vomiting in pregnancy was studied in a historical cohort of 825 women who gave birth at the University of California (Los Angeles) Medical Center during a one-year period (April 1983-March 1984). The roles of demographic factors, reproductive history, and consumption of alcohol and tobacco in affecting the risk of developing nausea and vomiting were studied using both bivariate and multivariate statistical methods. Interpretations of the statistical analyses identify three risk factor associations correlated with decreased risk of nausea and vomiting and one factor associated with increased risk. The most apparent pattern was that women who were ethnically white, of white collar or professional occupation, and who consumed alcohol prior to conception, were at decreased risk for nausea and vomiting. The second pattern of decreased risk consisted of women over 35 years old with a history of infertility for one or more years prior to the current conception. The third low-risk pattern consisted of women without a history of nausea during prior pregnancies. The only factor associated with an increased risk was housewife occupational status. The results of this study are consistent with an endocrinologic model for the etiology of pregnancy-induced nausea and vomiting.